FHC #234: The risks of moving too fast with AI & the dangers of standing still

Artificial intelligence is advancing at an extraordinary pace, and warnings about its dangers are becoming increasingly alarming. Technology companies are reporting troubling behavior from powerful AI systems, while researchers and government officials debate how to prevent potentially catastrophic consequences.

But Dr. Robert Pearl sees another danger: What if fear of AI prevents medicine from using the technology to save lives?

In this episode of Diving Deep, Pearl and co-host Jeremy Corr begin by exploring the risks and opportunities of generative AI. Later in the episode, they offer another warning that healthcare leaders can no longer afford to ignore: America’s mounting economic pressures.

The medical dangers of standing still

Dr. Pearl begins by acknowledging the existential risks posed by increasingly powerful AI systems. Those threats demand serious safeguards, he says, but not every application carries the same level of danger.

Consider patients recovering from surgery, living with heart failure or managing chronic diseases such as hypertension and diabetes. Doctors know that more frequent monitoring could help identify complications earlier and improve outcomes. But most physicians lack the time to review daily blood-pressure readings, evaluate surgical wounds or track subtle changes in patients’ health between office visits.

Generative AI agents could help fill those gaps. Pearl draws on his experience leading The Permanente Medical Group, where more frequent monitoring contributed to substantial reductions in cardiovascular mortality and better control of hypertension. AI, he argues, could make comparable levels of attention more affordable and accessible nationwide.

What the bond market is telling healthcare

The second half of the episode shifts to another source of concern: America’s mounting debt and the rising cost of borrowing.

Pearl explains why bond-market trends should matter to physicians, hospitals, insurers and drug manufacturers. With federal debt exceeding $40 trillion, healthcare spending continuing to rise and employers struggling with escalating premiums, the financial pressures on American medicine are becoming increasingly difficult to ignore.

Yet healthcare organizations continue relying on familiar strategies: higher prices, tighter insurance restrictions, hospital consolidation and greater negotiating leverage.

Pearl argues that these approaches cannot remain effective indefinitely. Instead, he challenges four major sectors of healthcare to consider fundamentally different strategies:

• Insurers: Move beyond restricting access and embrace payment arrangements that reward better health and lower total costs.
• Physicians: Consider greater financial accountability through value-based contracts that reward prevention and effective chronic disease management.
• Hospitals: Shift their focus from maximizing inpatient revenue toward coordinated outpatient care that prevents avoidable hospitalizations.
• Drug manufacturers: Explore lower prices in exchange for expanded coverage and greater prescription volume.

Each approach involves risk. But Pearl warns that preserving the status quo may ultimately prove more dangerous than embracing change. He closes by describing what business strategists call an inflection point: a moment when existing assumptions no longer hold and leaders must make consequential decisions before the outcome becomes obvious.

The two discussions offer a common lesson for American healthcare. Whether confronting powerful new technology or mounting financial pressures, leaders cannot assume that avoiding change will protect them from risk. Listen to this episode of Diving Deep to explore how AI, economics and strategic decision-making could reshape the future of medicine.

s